Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Oncology | Gastroenterology | Endocrinology | Family Medicine
Disease Category: Pancreatic Cancer
Location: United States, WV
ACOSOG-Z5041: Ph2 of Neoadjuvant and Adjuvant Gemcitabine Hydrochloride and Erlotinib Hydrochloride in pts + Resectable Adenocarcinoma of the Pancreas Undergoing Pancreatectomy.
The purpose of this study is to find out whether Gemcitabine Hydrochloride and Erlotinib Hydrochloride given prior to surgery, can help to increase the success of removing the entire pancreatic tumor. This study is also designed to answer the question of whether the same combination of chemotherapy can be given safely after surgery and reduce the chances of the cancer returning after surgery.
West Virginia University - Clinical Trials Research Unit
1637 Health Sciences South, PO Box 9260
Morgantown, WV 26506
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these